Likewise NETs share signaling pathways with renal cell carcinoma (RCC) and interestingly in RCC statins are known to inhibit the phosphorylation of AKT, mammalian target of rapamycin (mTOR), and ERK reducing cells motility [39]. The gene discussed is MTOR; the disease is hereditary clear cell renal cell carcinoma.